Abstract:OBJECTIVES:Neuroendocrine thymic tumours (NETTs) are a distinct subgroup of rare malignancies. An international, multicentre retrospective analysis was used to study the clinicopathological features, current pattern of diagnosis, treatment and outcomes of patients with NETT.METHODS:One hundred and forty-six NETT treated from 1989 to 2016 at 21 centres in China, Europe and North America were retrospectively collected and reclassified according to the World Health Organization histological type and International Thymic Malignancy Interest Group (ITMIG)/International Association for Studies in Lung Cancer (IASLC)/Union for International Cancer Control (UICC) staging. Clinicopathological features, diagnostic and therapeutic approaches and outcomes were investigated. Results in the earlier and latter halves of the study period were also compared.RESULTS:The pretreatment work-up relied exclusively on computed tomography in 85.6% (125/146) of cases. Most patients had advanced disease, with 32.2% (47/146) having lymph node involvement. Higher-grade histological type was associated with more advanced disease (P < 0.05). Induction therapies and surgical procedures were used more often in the latter half of the study. However, the complete resection rate remained unchanged, being 71.5% (98/137) in the whole group. Complete resection was associated with significantly longer 5-year overall survival (77.2% vs 51.2%; P < 0.001) than incomplete or no resection. Significant survival differences were seen with the T, N and M categories of ITMIG/IASLC/UICC staging. Poorly differentiated carcinoma, ITMIG/IASLC/UICC stage IIIa or above and incomplete or no resection were independent risk factors for worse survival. No survival difference was noted between the earlier and the latter halves of the study (58.2% vs 71.9%; P = 0.299).CONCLUSIONS:Current management similar to that for thymomas is unsatisfactory in providing disease control or long-term survival for patients with NETT. Specific diagnostic tools and novel therapeutic agents are needed to improve management outcomes of this disease.

Clinicopathological Features and Current Treatment Outcomes of Neuroendocrine Thymic Tumours

Treatment of Primary Hepatic Neuroendocrine Tumors

Thymic Neuroendocrine Tumors: an Analysis of 18 Cases and a Literature Review

Clinical Features and Prognosis of Thymic Neuroendocrine Tumours Associated with Multiple Endocrine Neoplasia Type 1: A Single-Centre Study, Systematic Review and Meta-Analysis

Early diagnosis and treatment of gastrointestinal neuroendocrine tumors.

Effect of Clinicopathologic Features on Survival of Patients with Thymic Carcinomas and Thymic Neuroendocrine Tumors: A Population-Based Analysis.

Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study

Imaging and Histopathological Features Of Primary Thymic Neuroendocrine Tumor

Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3

Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST)

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis

Low to intermediate grade lung neuroendocrine tumours. A single centre real world experience

Clinicopathological features and outcome of esophageal neuroendocrine tumor: A retrospective multicenter survey by the digestive endoscopy society of Taiwan

Progress of Diagnosis and Treatment of Gastrointestinal Neuroendocrine Tumors

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

Evaluation of the Prognostic Value of Surgery and Postoperative Radiotherapy for Patients with Thymic Neuroendocrine Tumors: A Propensity‐matched Study Based on the SEER Database

Clinicopathological Characteristics of the primary and metastatic Hepatic Neuroendocrine Tumors and the relevant Prognosis-Related Factors: A Retrospective Study of 81 Cases in a Single Chinese Center.

Surgical Treatment and Clinical Outcome of Nonfunctional Pancreatic Neuroendocrine Tumors: a 14-Year Experience from One Single Center.

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms

Primary Neuroendocrine Tumors of the Endometrium: Management and Outcomes

Diagnosis and prognosis of neuroendocrine tumours of the lung by means of high resolution image analysis